Promaxo has developed a compact, office-based MRI system specifically designed for guiding targeted prostate biopsies and cancer treatments, achieving a 77% cancer detection rate. This technology enables earlier identification of aggressive prostate cancer, allowing for timely interventions without the need for major facility upgrades.
Funding
$59M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MSFounders
Product
Problem
Traditional prostate cancer diagnosis often relies on standard-of-care methods that may miss clinically significant cancers, leading to delayed or inadequate treatment. Existing MRI systems are typically large, expensive, and require specialized facilities, limiting accessibility for urologists and patients. This can result in delayed diagnoses and increased healthcare costs.
Solution
Promaxo offers a compact, in-office MRI system designed specifically for prostate imaging and targeted interventions. This system enables urologists to perform MRI-guided prostate biopsies and treatments directly within their existing clinic space, eliminating the need for hospital referrals or major facility upgrades. The Promaxo MRI system boasts a high cancer detection rate and improved visualization of clinically significant lesions, leading to earlier and more accurate diagnoses. By integrating seamlessly into the urology workflow, the Promaxo system enhances diagnostic confidence and facilitates personalized prostate cancer care.
Target Audience
The primary target audience includes urologists and urology practices seeking to improve prostate cancer diagnosis and treatment within their office setting.
Features
- Compact MRI system designed for in-office installation without major facility modifications
- High cancer detection rate (77%) compared to standard-of-care methods
- MRI-guided prostate biopsy and treatment capabilities
- Enhanced visualization of clinically significant prostate lesions
- Streamlined workflow allowing for simultaneous clinic operation and MRI-targeted interventions
- AI-driven image analysis for improved diagnostic accuracy